Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lilly bar-coding plans

Executive Summary

FDA expects manufacturers will comply with bar coding proposed regulation before the rule takes effect. "Manufacturers, I think, are going to end up complying with this fairly quickly," Commissioner McClellan tells analysts. "We heard from Lilly, for example, earlier this month who said that they think the vast majority of their products will have bar codes by the end of the year." FDA published the proposed rule March 14; the agency expects to issues a final rule by year-end followed by a three-year implementation period (1"The Pink Sheet" March 17, p. 10)...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS041854

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel